Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • Green360 Secures Holcim as First Commercial Eco-Clay Customer in Major Validation Milestone
    Green360 Secures Holcim as First Commercial Eco-Clay Customer in Major Validation Milestone
    • News

  • Aerometrex Expands MetroMap Partner Program as Scalable Model Gains Traction
    Aerometrex Expands MetroMap Partner Program as Scalable Model Gains Traction
    • News

  • Middle East Conflict Starts to Hurt Corporate Earnings Outlooks
    Middle East Conflict Starts to Hurt Corporate Earnings Outlooks
    • News

  • European Lithium and Critical Metals Secure Control of Tanbreez Rare Earth Project
    European Lithium and Critical Metals Secure Control of Tanbreez Rare Earth Project
    • News

  • Harris Technology’s refurbished boom signals FY26 profit inflection
    Harris Technology’s refurbished boom signals FY26 profit inflection
    • News

Progresses Benchmarking for EMASS Semiconductor Technology

  • In News
  • November 6, 2024
  • Tim Grey
Progresses Benchmarking for EMASS Semiconductor Technology
  • Second Benchmark testing for the ECS-DOT chipset by Embedded A.I Systems Pte. Ltd (EMASS) is scheduled to commence on 7 November, 2024, with results expected within a week
  • The tests will focus on two critical applications, Anomaly Detection and Keyword Spotting, using standardised workloads from the MLPerf Tiny AI suite
  • The EMASS ECS-DOT’s chipset performance will be compared against current System-on-a-Chip semiconductor leaders, STMicroelectronics and Syntiant
  • Benchmarking results will be released to the market upon completion
  • These tests provides an accelerated framework for commercialisation using the EMASS System on Chip technologies.

Nanoveu (ASX: NVU) has commenced the next phase in benchmark testing for the ECS-DOT chipset, developed by Embedded A.I Systems (EMASS). This step reinforces the Company’s strategy to leverage EMASS’s edge AI semiconductor chip technology and demonstrate its potential for industry-leading AI performance and energy consumption efficiency.

The benchmarking process will continue to evaluate the ECS-DOT System-on-a-Chip (SoC) using MLPerf Tiny benchmarking suite, an industry-standard suite providing reproducible, reliable assessments of SoC performance in speed, accuracy, and energy efficiency. The focus will be on two key applications: (1) Anomaly Detection and (2) Keyword Spotting. Both these tasks are crucial for real-time AI applications in fields ranging from industrial IoT and consumer electronics to 2D-3D visual data transformation.

Commenting on the benchmarking, Alfred Chong, Managing Director and CEO of Nanoveu said: “As we continue to expand the EyeFly3D™ platform’s reach, these benchmarking tests are a pivotal step in preparing for EMASS chipset integration. This phase enables us to validate the performance of ECS-DOT chipset in powering next-generation 3D experiences. By demonstrating the chipset’s strengths in tasks like anomaly detection and keyword spotting, we’re positioning EMASS to meet the growing demand for powerful, energy-efficient SoCs with advanced image processing capabilities across industries like smart home systems, robotics, autonomous driving, and medical imaging.”

  • About
  • Latest Posts
Tim Grey
Latest posts by Tim Grey (see all)
  • AML3D announces stronger FY26, with positive EBITDA reported in the second half - September 1, 2026
  • Imagion Biosystems Advances MagSense® Phase 2 Trial - August 27, 2026
  • Acrux-developed Menopause Hormone Therapy to enter Australian market - May 28, 2026
  •  
  •  
  •  
  •  
  • asx nvu
  • News

Leave a Comment

You must be logged in to post a comment.

1 Comment

  • Shraddha13
    February 7, 2025, 9:10 pm

    Thank you for sharing! To explore further
    https://www.360iresearch.com/library/intelligence/semiconductor-valve

    Reply
  • About
  • Latest Posts
Tim Grey
Latest posts by Tim Grey (see all)
  • AML3D announces stronger FY26, with positive EBITDA reported in the second half - September 1, 2026
  • Imagion Biosystems Advances MagSense® Phase 2 Trial - August 27, 2026
  • Acrux-developed Menopause Hormone Therapy to enter Australian market - May 28, 2026

Login or register for free to access unlimited reading

Register Now!
  • About
  • Latest Posts
Tim Grey
Latest posts by Tim Grey (see all)
  • AML3D announces stronger FY26, with positive EBITDA reported in the second half - September 1, 2026
  • Imagion Biosystems Advances MagSense® Phase 2 Trial - August 27, 2026
  • Acrux-developed Menopause Hormone Therapy to enter Australian market - May 28, 2026
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.